Neoadjuvant Pembrolizumab is Active in Surgically Resected Head and Neck CancerSarah Palackdharry, Trisha M. Wise‐Draper, Francis P. Worden et al.|International Journal of Radiation Oncology*Biology*Physics|2018Cited by 1